The drug survival of adalimumab compared to etanercept and infliximab in treatment of patients with rheumatoid arthritis in daily clinical practice

W. Kievit; J. Fransen; H.H. Kuper; M.A.F.J. van de Laar; D.J.R.A. Rooij; C.M.A. de Gendt; T.L. Jansen; K.H. Ronday; H.L.C. Brus; J.D. Moolenburgh; M. Janson; P.C.M. van Oijen; E.M. Adang; P.L. van Riel

The drug survival of adalimumab compared to etanercept and infliximab in treatment of patients with rheumatoid arthritis in daily clinical practice

W. Kievit, J. Fransen, H.H. Kuper, M.A.F.J. van de Laar, D.J.R.A. Rooij, C.M.A. de Gendt, T.L. Jansen, K.H. Ronday, H.L.C. Brus, J.D. Moolenburgh, M. Janson, P.C.M. van Oijen, E.M. Adang, P.L. van Riel

Research output: Contribution to conference › Poster › Other research output

Original language	English
Pages	-
Publication status	Published - 21 Jun 2006
Event	EULAR Annual European Congress of Rheumatology 2006 - Amsterdam, Netherlands Duration: 21 Jun 2006 → 24 Jun 2006

Conference

Conference	EULAR Annual European Congress of Rheumatology 2006
Abbreviated title	EULAR 2006
Country/Territory	Netherlands
City	Amsterdam
Period	21/06/06 → 24/06/06

Keywords

METIS-235830

Cite this

Kievit, W., Fransen, J., Kuper, H. H., van de Laar, M. A. F. J., Rooij, D. J. R. A., de Gendt, C. M. A., Jansen, T. L., Ronday, K. H., Brus, H. L. C., Moolenburgh, J. D., Janson, M., van Oijen, P. C. M., Adang, E. M., & van Riel, P. L. (2006). The drug survival of adalimumab compared to etanercept and infliximab in treatment of patients with rheumatoid arthritis in daily clinical practice. -. Poster session presented at EULAR Annual European Congress of Rheumatology 2006, Amsterdam, Netherlands.

@conference{d951e13ba95046069be3aa0e88b2b7b3,

title = "The drug survival of adalimumab compared to etanercept and infliximab in treatment of patients with rheumatoid arthritis in daily clinical practice",

keywords = "METIS-235830",

author = "W. Kievit and J. Fransen and H.H. Kuper and {van de Laar}, M.A.F.J. and D.J.R.A. Rooij and {de Gendt}, C.M.A. and T.L. Jansen and K.H. Ronday and H.L.C. Brus and J.D. Moolenburgh and M. Janson and {van Oijen}, P.C.M. and E.M. Adang and {van Riel}, P.L.",

year = "2006",

month = jun,

day = "21",

language = "English",

pages = "--",

note = "EULAR Annual European Congress of Rheumatology 2006, EULAR 2006 ; Conference date: 21-06-2006 Through 24-06-2006",

}

Kievit, W, Fransen, J, Kuper, HH, van de Laar, MAFJ, Rooij, DJRA, de Gendt, CMA, Jansen, TL, Ronday, KH, Brus, HLC, Moolenburgh, JD, Janson, M, van Oijen, PCM, Adang, EM & van Riel, PL 2006, 'The drug survival of adalimumab compared to etanercept and infliximab in treatment of patients with rheumatoid arthritis in daily clinical practice', EULAR Annual European Congress of Rheumatology 2006, Amsterdam, Netherlands, 21/06/06 - 24/06/06 pp. -.

The drug survival of adalimumab compared to etanercept and infliximab in treatment of patients with rheumatoid arthritis in daily clinical practice. / Kievit, W.; Fransen, J.; Kuper, H.H. et al.
2006. - Poster session presented at EULAR Annual European Congress of Rheumatology 2006, Amsterdam, Netherlands.

Research output: Contribution to conference › Poster › Other research output

TY - CONF

T1 - The drug survival of adalimumab compared to etanercept and infliximab in treatment of patients with rheumatoid arthritis in daily clinical practice

AU - Kievit, W.

AU - Fransen, J.

AU - Kuper, H.H.

AU - van de Laar, M.A.F.J.

AU - Rooij, D.J.R.A.

AU - de Gendt, C.M.A.

AU - Jansen, T.L.

AU - Ronday, K.H.

AU - Brus, H.L.C.

AU - Moolenburgh, J.D.

AU - Janson, M.

AU - van Oijen, P.C.M.

AU - Adang, E.M.

AU - van Riel, P.L.

PY - 2006/6/21

Y1 - 2006/6/21

KW - METIS-235830

M3 - Poster

SP - -

T2 - EULAR Annual European Congress of Rheumatology 2006

Y2 - 21 June 2006 through 24 June 2006

ER -